__NUXT_JSONP__("/drugs/Farletuzumab", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"896723-44-7",chebiId:b,chemicalFormula:b,definition:"A humanized, immunoglobulin G1 monoclonal antibody with potential antitumor activity. Farletuzumab specifically targets at glycoprotein 3 (GP-3), a cell surface antigen that is overexpressed on many epithelial-derived cancer cells. Upon binding to the GP-3 antigen, farletuzumab triggers a host immune response against GP-3 expressing cells resulting in cell lysis.",fdaUniiCode:"2O09BG0OWA",identifier:"C61503",preferredName:a,semanticType:"Amino Acid, Peptide, or Protein",subclassOf:["C20401"],synonyms:["FARLETUZUMAB",a,"MORAb-003"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FFarletuzumab",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Farletuzumab","","2021-10-30T13:41:33.493Z")));